Trial Profile
IClyCO Influence of Chemotherapy (Carboplatin and Taxol) on the ex Vivo Expansion and Functional Capacity of Gamma-delta T Cells in Patients With Epithelial Ovarian Cancer
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase IV
Latest Information Update: 17 Jun 2015
Price :
$35
*
At a glance
- Drugs Carboplatin (Primary) ; Paclitaxel (Primary)
- Indications Ovarian cancer
- Focus Pharmacodynamics
- Acronyms IClyCO
- 30 May 2012 New trial record